FDA product code SAP: Computerized Behavioral Therapy Device For Depressive Disorders.

SAP is the FDA product code for computerized behavioral therapy device for depressive disorders.. It is a Class II device, regulated under 21 CFR 882.5801 and reviewed by the Neurology panel. FDA has cleared 3 510(k) submissions under SAP, 3 in the last five years, from 3 different applicants. The average 510(k) review took 360 days (median 338); 327 days on average over the last three years.

Definition

The device is intended to provide computerized behavioral therapy to treat depressive disorders.

Classification

FieldValue
Device nameComputerized Behavioral Therapy Device For Depressive Disorders.
Device classClass II
Regulation21 CFR 882.5801
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)

510(k) clearances per year for SAP

YearClearancesAvg. review days
20242428
20261226

Compare with all 510(k) review times · Search every SAP clearance

Top SAP applicants

ApplicantClearancesLatest
Click Therapeutics, Inc.12026-07-30
Curio Digital Therapeutics, Inc.12024-04-22
Otsuka America Pharmaceutical, Inc.12024-03-30

Most recent SAP clearances

510(k)ApplicantDeviceDecision dateReview days
K254038Click Therapeutics, Inc.Motivista (CT-155)2026-07-30226
K223515Curio Digital Therapeutics, Inc.MamaLift Plus2024-04-22517
K231209Otsuka America Pharmaceutical, Inc.Rejoyn2024-03-30338

Recalls for SAP devices

openFDA lists no recalls for product code SAP.

Frequently asked questions

What is FDA product code SAP?

SAP is the FDA product code for computerized behavioral therapy device for depressive disorders.. It is a Class II device, regulated under 21 CFR 882.5801 and reviewed by the Neurology panel.

What device class is SAP?

Class II, regulation 21 CFR 882.5801. Typical premarket route: 510(k).

How long does a 510(k) take for product code SAP?

Across 3 cleared submissions the average was 360 days from receipt to decision (median 338).

Which companies have the most SAP clearances?

Click Therapeutics, Inc. (1); Curio Digital Therapeutics, Inc. (1); Otsuka America Pharmaceutical, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times